Demi Krieger1, Caroline Abe1, Alexandra Pottorff1, Xilong Li2, Josiah Rich3, Ank E Nijhawan2,4,5. 1. From the University of Texas Southwestern Medical Center, Dallas, TX. 2. Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX. 3. Department of Internal Medicine and Epidemiology, Warren Alpert Medical School of Brown University, Providence, RI. 4. Division of Infectious Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center. 5. Parkland Health and Hospital Systems, Dallas, TX.
Abstract
BACKGROUND: Incarceration and human immunodeficiency virus (HIV) are associated with sexually transmitted infections (STIs); however, little is known about STI prevalence among people living with HIV (PLWH) during and after incarceration. METHODS: Electronic medical records from the Dallas County Jail and community HIV clinics were reviewed to determine the frequency and results of testing for gonorrhea, chlamydia, syphilis, and hepatitis B virus (HBV) among PLWH incarcerated in Dallas County Jail between 2010 and 2013. HIV viral loads (VL) and evidence of STI symptoms and treatment were also collected. RESULTS: During 2473 incarcerations, 6 (3%) of 190 tests were positive for gonorrhea, 7 (4%) of 190 for chlamydia, 231 (21%) of 1082 for syphilis, of which 53 (23%) were new diagnoses, and 48 (5%) of 1005 for HBV surface antigen. Among 1631 releases to the community, 808 followed up in community clinics, where 21 (4%) 553 tests were positive for gonorrhea, 23 (4%) of 555 for chlamydia, 150 (19%) of 808 for syphilis, of which 31 (21%) were new diagnoses, and 24 (6%) of 421 for HBV surface antigen. The majority of new STI cases, 51 (80%) of 64 in jail and 43 (77%)of 56 in the community, had a concurrent detectable (>200 copies/mL) HIV VL. CONCLUSIONS: Testing for gonorrhea and chlamydia was low, particularly in jail, which was attributed to testing protocols. High proportions of PLWH tested positive for syphilis and HBV infection in both settings. The majority of patients with active STIs had a detectable HIV VL. Routine, opt-out screening for STIs for PLWH during and after incarceration has the potential to identify a high proportion of STIs and improve secondary HIV prevention.
BACKGROUND: Incarceration and human immunodeficiency virus (HIV) are associated with sexually transmitted infections (STIs); however, little is known about STI prevalence among people living with HIV (PLWH) during and after incarceration. METHODS: Electronic medical records from the Dallas County Jail and community HIV clinics were reviewed to determine the frequency and results of testing for gonorrhea, chlamydia, syphilis, and hepatitis B virus (HBV) among PLWH incarcerated in Dallas County Jail between 2010 and 2013. HIV viral loads (VL) and evidence of STI symptoms and treatment were also collected. RESULTS: During 2473 incarcerations, 6 (3%) of 190 tests were positive for gonorrhea, 7 (4%) of 190 for chlamydia, 231 (21%) of 1082 for syphilis, of which 53 (23%) were new diagnoses, and 48 (5%) of 1005 for HBV surface antigen. Among 1631 releases to the community, 808 followed up in community clinics, where 21 (4%) 553 tests were positive for gonorrhea, 23 (4%) of 555 for chlamydia, 150 (19%) of 808 for syphilis, of which 31 (21%) were new diagnoses, and 24 (6%) of 421 for HBV surface antigen. The majority of new STI cases, 51 (80%) of 64 in jail and 43 (77%)of 56 in the community, had a concurrent detectable (>200 copies/mL) HIV VL. CONCLUSIONS: Testing for gonorrhea and chlamydia was low, particularly in jail, which was attributed to testing protocols. High proportions of PLWH tested positive for syphilis and HBV infection in both settings. The majority of patients with active STIs had a detectable HIV VL. Routine, opt-out screening for STIs for PLWH during and after incarceration has the potential to identify a high proportion of STIs and improve secondary HIV prevention.
Authors: Kristen J Mertz; Jane R Schwebke; Charlotte A Gaydos; Heidi A Beidinger; Scott D Tulloch; William C Levine Journal: Sex Transm Dis Date: 2002-05 Impact factor: 2.830
Authors: Marjan Javanbakht; Ryan Murphy; Nina T Harawa; Lisa V Smith; Mary Hayes; Michael Chien; Peter R Kerndt Journal: Sex Transm Dis Date: 2009-02 Impact factor: 2.830
Authors: James C Thomas; Brooke A Levandowski; Malika Roman Isler; Elizabeth Torrone; George Wilson Journal: J Urban Health Date: 2007-11-29 Impact factor: 3.671
Authors: Robert J Carpenter; Oliver N Refugio; Nehkonti Adams; Kevin P O'Brien; Mark D Johnson; Harold L Groff; Ryan C Maves; Mary F Bavaro; Nancy F Crum-Cianflone Journal: BMJ Open Date: 2013-05-28 Impact factor: 2.692
Authors: Marc M Solomon; Kenneth H Mayer; David V Glidden; Albert Y Liu; Vanessa M McMahan; Juan V Guanira; Suwat Chariyalertsak; Telmo Fernandez; Robert M Grant Journal: Clin Infect Dis Date: 2014-06-13 Impact factor: 9.079